510(k) K893508

PROSTATE SPECIFIC ANTIGEN IMMUNOHISTOCHEMICAL ANTI by Baxter Healthcare Corp — Product Code JFH

K893508 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "PROSTATE SPECIFIC ANTIGEN IMMUNOHISTOCHEMICAL ANTI". The FDA issued a decision of Substantially Equivalent on August 4, 1989. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 4, 1989
Date Received
May 5, 1989
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Acid Phosphatase (Prostatic), Tartrate Inhibited
Device Class
Class II
Regulation Number
862.1020
Review Panel
CH
Submission Type